Vous êtes ici

Biocure Technology Inc.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
CURE
Indice CSE: 
Devise: 

Biocure Technology Inc. is a biopharmaceutical company, specializing in the development and commercialization of major biosimilar products. Biocure is currently conducting pre-clinical trials of its biosimilar candidates of Interferon Beta 1b, PEG-Filgrastim and Ranibizumab as well as CAR-T Cell Therapy.

Vous êtes ici

Biocure Technology Inc. (CURE)

SEDAR Information

Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: mars 2, 2015
Biocure Technology Inc.
Date: janvier 16, 2015

Information d'entreprise

Addresse
300-1055 West Hastings Street
Vancouver, BC V6E 2E9
Canada
Téléphone
604-609-7146
Fax
N/A
Courriel
admin@biocuretech.com
URL
http://www.biocuretech.com
Date d’inscription à la cote
Lundi, mai 10, 2010
Relations avec les investisseurs
n/a
Vérificateur
DMCL Chartered Professional Accountants

Advertisement

Publicité

Capitalisation

Capitalisation: 
96,793,301
Réservé à l'émission: 

Bulletins

28/11/2017

2017-1117 – Changement Fondamental – Gravis Energy Corp./Biocure Technology Inc.

le 28 novembre/November 2017

Biocure Technology Inc., the issuer resulting from a Fundamental Change of Gravis Energy Corp. has been approved for listing.

Listing and disclosure documents will be available at thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Évènements à venir

10_29_2018_Canada_Fintech_Forum_CSE_Website

Canada FinTech Forum

Lundi, octobre 29, 2018 (Jour entier) - Mercredi, octobre 31, 2018 (Jour entier)
10_31_World_Crypto_Con_CSE_Website

World Crypto Con

Mercredi, octobre 31, 2018 (Jour entier) - Vendredi, novembre 2, 2018 (Jour entier)
11_07_2018_TakeStock_Investor_Forum_CSE_Website

TakeStock Investor Forum

Mercredi, novembre 7, 2018 -
08:30 - 17:30